De novo mutation in CACNA1A caused acetazolamide-responsive episodic ataxia

被引:0
|
作者
Yue, Q
Jen, JC
Thwe, MM
Nelson, SF
Baloh, RW
机构
[1] Univ Calif Los Angeles, Dept Neurol, Sch Med, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Dept Pediat Hematol & Oncol, Sch Med, Los Angeles, CA 90095 USA
[3] Univ Calif Los Angeles, Dept Head & Neck Surg, Sch Med, Los Angeles, CA 90095 USA
来源
AMERICAN JOURNAL OF MEDICAL GENETICS | 1998年 / 77卷 / 04期
关键词
calcium channel gene; episodic ataxia; acetazolamide; de novo mutation;
D O I
10.1002/(SICI)1096-8628(19980526)77:4<298::AID-AJMG9>3.0.CO;2-J
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
With the recent report of mutations in the calcium channel gene CACNA1A in two families with episodic ataxia type 2, we investigated a patient with nonfamilial episodic vertigo and ataxia responsive to acetazolamide for similar mutations. Single-strand conformation polymorphism (SSCP) analysis of exon 23 identified an extra band in the patient that was not present in other relatives or in normal controls. Exon 23 of the patient showed a spontaneous C to T substitution at position 4410 resulting in an early stop codon. Patients with nonfamilial episodic ataxia may respond to acetazolamide and may have mutations in CACNA1A. (C) 1998 Wiley-Liss, Inc.
引用
收藏
页码:298 / 301
页数:4
相关论文
共 50 条
  • [41] Novel splice site CACNA1A mutation causing episodic ataxia type 2
    M. A. Kaunisto
    H. Harno
    M. Kallela
    H. Somer
    R. Sallinen
    E. Hämäläinen
    P.J. Miettinen
    J. Vesa
    A. Orpana
    A. Palotie
    M. Färkkilä
    M. Wessman
    Neurogenetics, 2004, 5 : 69 - 73
  • [42] A novel mutation of CACNA1A gene in episodic ataxia type 2 family in Korea
    Shin, Kyong Jin
    Park, Jinse
    Oh, Seung Hwan
    Jun, Kyung Ran
    Park, Kang Min
    Ha, Sam Yeol
    EunKim, Sung
    Jang, Wooyoung
    Kim, Ji Sun
    Youn, Jinyoung
    Oh, Eungseok
    Kim, Hee-Tae
    NEUROLOGY ASIA, 2014, 19 (04) : 363 - 366
  • [43] Acetazolamide-responsive exercise-induced episodic ataxia associated with a novel homozygous DARS2 mutation
    Synofzik, Matthis
    Schicks, Julia
    Lindig, Tobias
    Biskup, Saskia
    Schmidt, Thorsten
    Hansel, Jochen
    Lehmann-Horn, Frank
    Schoels, Ludger
    JOURNAL OF MEDICAL GENETICS, 2011, 48 (10) : 713 - 715
  • [44] A novel CACNA1A mutation results in episodic ataxia with migrainous features without headache
    Magis, Delphine
    Boon, Elles
    Coppola, Gianluca
    Daron, Aurore
    Schoenen, Jean
    CEPHALALGIA, 2012, 32 (15) : 1147 - 1149
  • [45] Sporadic hemiplegic migraine with de novo CACNA1A missense mutation
    Vahedi, K
    Denier, C
    Ducros, A
    Bousson, V
    Levy, C
    Haguenau, M
    Tournier-Lasserve, E
    Bousser, MG
    NEUROLOGY, 1999, 52 (06) : A274 - A274
  • [46] CACNA1A mutation in a EA-2 patient responsive to acetazolamide and valproic acid
    Scoggan, KA
    Friedman, JH
    Bulman, DE
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2006, 33 (01) : 68 - 72
  • [47] A de novo mutation in CACNA1A is associated with autosomal dominant bovine familial convulsions and ataxia in Angus cattle
    Reith, Rachel R.
    Beever, Jonathan E.
    Paschal, Joe C.
    Banta, Jason
    Porter, Brian F.
    Steffen, David J.
    Hairgrove, Thomas B.
    Petersen, Jessica L.
    ANIMAL GENETICS, 2024, 55 (03) : 344 - 351
  • [48] Acetazolamide-responsive periodic ataxia induced by amiodarone
    Onofrj, M
    Thomas, A
    MOVEMENT DISORDERS, 1999, 14 (02) : 379 - 381
  • [49] ACETAZOLAMIDE-RESPONSIVE PERIODIC ATAXIA AND PERIODIC PARALYSIS
    ZASORIN, N
    BALOH, R
    MEYERS, L
    NEUROLOGY, 1982, 32 (04) : A80 - A81
  • [50] Episodic ataxia type 2: phenotype characteristics of a novel CACNA1A mutation and review of the literature
    Nachbauer, Wolfgang
    Nocker, Michael
    Karner, Elfriede
    Stankovic, Iva
    Unterberger, Iris
    Eigentler, Andreas
    Schneider, Rainer
    Poewe, Werner
    Delazer, Margarete
    Boesch, Sylvia
    JOURNAL OF NEUROLOGY, 2014, 261 (05) : 983 - 991